Revvity, Inc. (RVTY)
130.22
-0.41
(-0.31%)
USD |
NYSE |
Sep 04, 16:00
130.65
+0.43
(+0.33%)
After-Hours: 20:00
Revvity Research and Development Expense (Quarterly) : 48.97M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 48.97M |
| March 31, 2026 | 57.89M |
| December 31, 2025 | 58.18M |
| September 30, 2025 | 50.80M |
| June 30, 2025 | 53.27M |
| March 31, 2025 | 53.60M |
| December 31, 2024 | 49.21M |
| September 30, 2024 | 49.14M |
| June 30, 2024 | 48.13M |
| March 31, 2024 | 50.36M |
| December 31, 2023 | 49.60M |
| September 30, 2023 | 53.04M |
| June 30, 2023 | 57.25M |
| March 31, 2023 | 56.69M |
| December 31, 2022 | 54.54M |
| September 30, 2022 | 53.52M |
| June 30, 2022 | 56.04M |
| March 31, 2022 | 76.61M |
| December 31, 2021 | 60.58M |
| September 30, 2021 | 49.42M |
| June 30, 2021 | 65.82M |
| March 31, 2021 | 60.22M |
| December 31, 2020 | 56.82M |
| September 30, 2020 | 50.13M |
| June 30, 2020 | 49.52M |
| Date | Value |
|---|---|
| March 31, 2020 | 48.91M |
| December 31, 2019 | 47.64M |
| September 30, 2019 | 45.38M |
| June 30, 2019 | 48.34M |
| March 31, 2019 | 47.98M |
| December 31, 2018 | 47.87M |
| September 30, 2018 | 45.15M |
| June 30, 2018 | 47.20M |
| March 31, 2018 | 45.98M |
| December 31, 2017 | 37.63M |
| September 30, 2017 | 34.79M |
| June 30, 2017 | 33.56M |
| March 31, 2017 | 33.29M |
| December 31, 2016 | 32.93M |
| September 30, 2016 | 29.41M |
| June 30, 2016 | 31.67M |
| March 31, 2016 | 29.77M |
| December 31, 2015 | 29.93M |
| September 30, 2015 | 31.00M |
| June 30, 2015 | 32.58M |
| March 31, 2015 | 32.02M |
| December 31, 2014 | 30.77M |
| September 30, 2014 | 30.24M |
| June 30, 2014 | 30.25M |
| March 31, 2014 | 29.25M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 120.00M |
| Thermo Fisher Scientific, Inc. | 364.00M |
| Danaher Corp. | 412.00M |
| Waters Corp. | 121.00M |
| Bio-Rad Laboratories, Inc. | 61.20M |